RXRX
Recursion Pharmaceuticals Inc
3.80$
+8.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.01 | 0.02 | 0.06 | 0.23 | 0.21 | 0.21 | 0.17 | |
| 0.28 | 0.38 | 0.05 | 0.28 | 0.20 | 0.16 | 0.27 | |
| -0.27 | 0.02 | 0.06 | -0.05 | 0.01 | 0.05 | -0.10 | |
| 0.28 | 0.38 | 0.79 | 0.89 | 1.16 | 1.15 | 0.95 | |
| 0.11 | 0.15 | 0.34 | 0.46 | 0.53 | 0.65 | 0.39 | |
| 0.39 | 0.53 | 1.13 | 1.35 | 1.69 | 1.80 | 1.35 | |
| -0.38 | -0.51 | -1.07 | -1.40 | -1.68 | -1.75 | -1.45 | |
| 0.00 | 0.01 | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 | |
| -0.37 | -0.52 | -1.10 | -1.36 | -1.60 | -1.70 | -1.44 | |
| 0.00 | 0.01 | -0.05 | 0.00 | -0.02 | 0.00 | 0.00 | |
| -0.38 | -0.52 | -1.05 | -1.36 | -1.58 | -1.69 | -1.44 | |
| -0.35 | -0.49 | -1.02 | -1.33 | -1.48 | -1.56 | -1.25 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.